SO
NGNE icon

STRS Ohio’s Neurogene NGNE Stock Holding History

STRS Ohio’s Portfolio NGNE Stock Details NGNE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-380
Closed -$91K – 2241
2020
Q3 		$91K Hold
380
– – ﹤0.01% 1863
2020
Q2 		$126K Buy
+380
New +$99.1K ﹤0.01% 1745

Other funds holding NGNE

RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PAMU
Pictet Asset Management (UK) London, United Kingdom $91.8B AUM 47.77% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

STRS Ohio's NGNE Position: Q4 2020 in Review

STRS Ohio sold out of Neurogene (NGNE) in Q4 2020, closing a stake of 380 shares — an estimated $91K sold.

STRS Ohio first reported a position in NGNE in Q2 2020 and held it in 2 quarters. The position peaked at $126K in Q2 2020. 84 funds tracked by Wall St. Rank hold NGNE as of Q4 2020.

  • STRS Ohio reported no remaining Neurogene position as of Q4 2020 after selling out during the quarter.
  • STRS Ohio sold 380 Neurogene shares in Q4 2020, an estimated $91K.
  • STRS Ohio first reported a position in Neurogene in Q2 2020 and held it in 2 quarters.
  • STRS Ohio's Neurogene position peaked at $126K in Q2 2020.
  • 84 funds tracked by Wall St. Rank held Neurogene as of Q4 2020.

Based on STRS Ohio's 13F filing for Q4 2020, filed 25 Jan 2021.